Fesarius Therapeutics Closes $20M Series A for Dermal Repair
Fundraise Insider tracks newly funded startups each week and delivers verified B2B leads list of C-suite contacts straight to your inbox, so you reach the right people while the funding is still fresh. See pricing.
Fesarius Therapeutics has closed an oversubscribed $20 million Series A financing, giving the medical device company room to push its dermal repair technology further into the commercial market. The round closed on June 10, 2026.
The financing was anchored by Jefferson Life Sciences, with additional backing from Johnson & Johnson through its corporate venture arm Johnson & Johnson Innovation, known as JJDC, Inc. Empire State Development’s NY Ventures also took part, fitting for a company headquartered in Brooklyn, New York. The American Society of Plastic Surgeons joined as well, marking the organization’s first institutional investment.
At the heart of the company’s work is DermiSphere, described as the first hydrogel Dermal Regeneration Template of its kind on the U.S. market. The product received FDA clearance in 2025 for managing a range of wound types, and the company is now focused on getting it into wider clinical use.
The new capital is earmarked for several priorities. Fesarius plans to expand its commercial infrastructure and broaden national market coverage. The company also intends to pursue Breakthrough Device Designation along with improved reimbursement pathways, two factors that often determine how quickly a medical device reaches patients at scale. Beyond that, the funds will support clinical studies for its OneStep procedure.
The investment reflects growing interest in regenerative wound care, a field where companies are working to move beyond traditional treatments toward technologies that help the body rebuild damaged tissue. For Fesarius, the close of this round is less about proving the science, which already has regulatory clearance behind it, and more about building the commercial machinery to get DermiSphere into the hands of surgeons across the country.